{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:02:34Z","timestamp":1777982554904,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T00:00:00Z","timestamp":1776556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T00:00:00Z","timestamp":1776556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"General Project of the Basic Research Program of Guizhou Provincial Department of Science and Technology","award":["grant no. Qiankehe Jichu-ZK [2022] General 472"],"award-info":[{"award-number":["grant no. Qiankehe Jichu-ZK [2022] General 472"]}]},{"name":"Guizhou Provincial Science and Technology Projects","award":["grant no. Qiankehe Pingtai ZSYS[2025]016)."],"award-info":[{"award-number":["grant no. Qiankehe Pingtai ZSYS[2025]016)."]}]},{"name":"General Project of Basic Research Plan of Guizhou Provincial Department of Science Technology","award":["grant no. Qiankehe Jichu ZK[2024] General 361"],"award-info":[{"award-number":["grant no. Qiankehe Jichu ZK[2024] General 361"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China project","doi-asserted-by":"crossref","award":["grant no. 82560779"],"award-info":[{"award-number":["grant no. 82560779"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"DOI":"10.1007\/s13346-026-02123-8","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T19:58:11Z","timestamp":1776628691000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ginsenoside Rh2-modified liposomes for targeted delivery of Puerarin alleviate brain ischemia\u2013reperfusion injury"],"prefix":"10.1007","author":[{"given":"Meiyan","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinglan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengbin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YongPing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,19]]},"reference":[{"key":"2123_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10040630","author":"A-M Aloizou","year":"2021","unstructured":"Aloizou A-M, Siokas V, Pateraki G, et al. Thinking outside the ischemia box: advancements in the use of multiple sclerosis drugs in ischemic stroke. J Clin Med. 2021. https:\/\/doi.org\/10.3390\/jcm10040630.","journal-title":"J Clin Med"},{"issue":"1","key":"2123_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/17474930211065917","volume":"17","author":"VL Feigin","year":"2022","unstructured":"Feigin VL, Brainin M, Norrving B, et al. World Stroke Organization (WSO): global stroke fact sheet 2022. Int J Stroke. 2022;17(1):18\u201329. https:\/\/doi.org\/10.1177\/17474930211065917.","journal-title":"Int J Stroke"},{"issue":"3","key":"2123_CR3","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1161\/strokeaha.120.032810","volume":"52","author":"P Jolugbo","year":"2021","unstructured":"Jolugbo P, Ari\u00ebns RAS. Thrombus composition and efficacy of thrombolysis and thrombectomy in acute ischemic stroke. Stroke. 2021;52(3):1131\u201342. https:\/\/doi.org\/10.1161\/strokeaha.120.032810.","journal-title":"Stroke"},{"issue":"34","key":"2123_CR4","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.2174\/0929867328666210921161711","volume":"29","author":"IK Koutsaliaris","year":"2022","unstructured":"Koutsaliaris IK, Moschonas IC, Pechlivani LM, Tsouka AN, Tselepis AD. Inflammation, oxidative stress, vascular aging and atherosclerotic ischemic stroke. Curr Med Chem. 2022;29(34):5496\u2013509. https:\/\/doi.org\/10.2174\/0929867328666210921161711.","journal-title":"Curr Med Chem"},{"key":"2123_CR5","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.phrs.2016.07.038","volume":"111","author":"R Roskoski","year":"2016","unstructured":"Roskoski R. Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases. Pharmacol Res. 2016;111:784\u2013803. https:\/\/doi.org\/10.1016\/j.phrs.2016.07.038.","journal-title":"Pharmacol Res"},{"key":"2123_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.113820","volume":"270","author":"C Liu","year":"2021","unstructured":"Liu C, Zhao Q, Zhong L, et al. Tibetan medicine ershiwuwei lvxue pill attenuates collagen-induced arthritis via inhibition of JAK2\/STAT3 signaling pathway. J Ethnopharmacol. 2021;270:113820. https:\/\/doi.org\/10.1016\/j.jep.2021.113820.","journal-title":"J Ethnopharmacol"},{"key":"2123_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101927","volume":"87","author":"A-F Radu","year":"2023","unstructured":"Radu A-F, Bungau SG. Nanomedical approaches in the realm of rheumatoid arthritis. Ageing Res Rev. 2023;87:101927. https:\/\/doi.org\/10.1016\/j.arr.2023.101927.","journal-title":"Ageing Res Rev"},{"issue":"3","key":"2123_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/08982104.2019.1634724","volume":"30","author":"KS Ahmed","year":"2020","unstructured":"Ahmed KS, Changling S, Shan X, et al. Liposome-based codelivery of celecoxib and doxorubicin hydrochloride as a synergistic dual-drug delivery system for enhancing the anticancer effect. J Liposome Res. 2020;30(3):285\u201396. https:\/\/doi.org\/10.1080\/08982104.2019.1634724.","journal-title":"J Liposome Res"},{"key":"2123_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110461","volume":"121","author":"S Paik","year":"2023","unstructured":"Paik S, Song GY, Jo E-K. Ginsenosides for therapeutically targeting inflammation through modulation of oxidative stress. Int Immunopharmacol. 2023;121:110461. https:\/\/doi.org\/10.1016\/j.intimp.2023.110461.","journal-title":"Int Immunopharmacol"},{"key":"2123_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910359","author":"S Feng","year":"2024","unstructured":"Feng S, Li T, Wei X, et al. The antioxidant and anti-fatigue effects of rare ginsenosides and \u03b3-aminobutyric acid in fermented ginseng and germinated brown rice puree. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms251910359.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2123_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s40820-020-00472-8","volume":"12","author":"C Hong","year":"2020","unstructured":"Hong C, Liang J, Xia J, et al. One stone four birds: a novel liposomal delivery system multi-functionalized with Ginsenoside Rh2 for tumor targeting therapy. Nano-Micro Lett. 2020;12(1):129. https:\/\/doi.org\/10.1007\/s40820-020-00472-8.","journal-title":"Nano-Micro Lett"},{"key":"2123_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.927611","volume":"13","author":"M Gao","year":"2022","unstructured":"Gao M, Zhang Z, Lai K, et al. Puerarin: a protective drug against ischemia-reperfusion injury. Front Pharmacol. 2022;13:927611. https:\/\/doi.org\/10.3389\/fphar.2022.927611.","journal-title":"Front Pharmacol"},{"issue":"12","key":"2123_CR13","doi-asserted-by":"publisher","first-page":"5107","DOI":"10.1016\/j.apsb.2023.06.011","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Zhang H, Zhao F, et al. Mitochondrial-targeted and ROS-responsive nanocarrier via nose-to-brain pathway for ischemic stroke treatment. Acta Pharm Sin B. 2023;13(12):5107\u201320. https:\/\/doi.org\/10.1016\/j.apsb.2023.06.011.","journal-title":"Acta Pharm Sin B"},{"issue":"6","key":"2123_CR14","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.17305\/bb.2024.10500","volume":"24","author":"X Zhao","year":"2024","unstructured":"Zhao X, Zhou J, Liu Y, et al. Puerarin alleviates osteoporosis in rats by targeting the JAK2\/STAT3 signaling pathway. Biomol Biomed. 2024;24(6):1651\u201361. https:\/\/doi.org\/10.17305\/bb.2024.10500.","journal-title":"Biomol Biomed"},{"key":"2123_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11112121","author":"D Wang","year":"2022","unstructured":"Wang D, Bu T, Li Y, et al. Pharmacological activity, pharmacokinetics, and clinical research progress of puerarin. Antioxidants. 2022. https:\/\/doi.org\/10.3390\/antiox11112121.","journal-title":"Antioxidants"},{"issue":"4","key":"2123_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0300467","volume":"19","author":"A Cazzolla","year":"2024","unstructured":"Cazzolla A, Mondala JRM, Wanigasekara J, et al. Synthesis of cationic liposome nanoparticles using a thin film dispersed hydration and extrusion method. PLoS ONE. 2024;19(4):e0300467. https:\/\/doi.org\/10.1371\/journal.pone.0300467.","journal-title":"PLoS ONE"},{"key":"2123_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-1-0716-2954-3_3","volume":"2622","author":"Q Zhong","year":"2023","unstructured":"Zhong Q, Zhang H. Preparation of small unilamellar vesicle liposomes using detergent dialysis method. Methods Mol Biol (Clifton, NJ). 2023;2622:49\u201356. https:\/\/doi.org\/10.1007\/978-1-0716-2954-3_3.","journal-title":"Methods Mol Biol (Clifton, N.J.)"},{"issue":"1","key":"2123_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-37187-w","volume":"13","author":"Y Li","year":"2023","unstructured":"Li Y, Tan L, Yang C, et al. Distinctions between the Koizumi and Zea Longa methods for middle cerebral artery occlusion (MCAO) model: a systematic review and meta-analysis of rodent data. Sci Rep. 2023;13(1):10247. https:\/\/doi.org\/10.1038\/s41598-023-37187-w.","journal-title":"Sci Rep"},{"issue":"1","key":"2123_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12868-022-00769-x","volume":"23","author":"L Yin","year":"2022","unstructured":"Yin L, Yu T, Cheng L, et al. Laser speckle contrast imaging for blood flow monitoring in predicting outcomes after cerebral ischemia-reperfusion injury in mice. BMC Neurosci. 2022;23(1):80. https:\/\/doi.org\/10.1186\/s12868-022-00769-x.","journal-title":"BMC Neurosci"},{"key":"2123_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.brainres.2008.11.048","volume":"1256","author":"J Cai","year":"2009","unstructured":"Cai J, Kang Z, Liu K, et al. Neuroprotective effects of hydrogen saline in neonatal hypoxia-ischemia rat model. Brain Res. 2009;1256:129\u201337. https:\/\/doi.org\/10.1016\/j.brainres.2008.11.048.","journal-title":"Brain Res"},{"issue":"1","key":"2123_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","volume":"65","author":"TM Allen","year":"2013","unstructured":"Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013;65(1):36\u201348. https:\/\/doi.org\/10.1016\/j.addr.2012.09.037.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"2123_CR22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1080\/08982104.2023.2226216","volume":"34","author":"H Nsairat","year":"2024","unstructured":"Nsairat H, Ibrahim AA, Jaber AM, et al. Liposome bilayer stability: emphasis on cholesterol and its alternatives. J Liposome Res. 2024;34(1):178\u2013202. https:\/\/doi.org\/10.1080\/08982104.2023.2226216.","journal-title":"J Liposome Res"},{"issue":"1","key":"2123_CR23","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2024.2324716","volume":"31","author":"H Ao","year":"2024","unstructured":"Ao H, Song H, Li J, Wang X. Enhanced anti-glioma activity of annonaceous acetogenins based on a novel liposomal co-delivery system with ginsenoside Rh2. Drug Deliv. 2024;31(1):2324716. https:\/\/doi.org\/10.1080\/10717544.2024.2324716.","journal-title":"Drug Deliv"},{"key":"2123_CR24","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.2147\/ijn.S437733","volume":"19","author":"C Hong","year":"2024","unstructured":"Hong C, Wang A, Xia J, et al. Ginsenoside Rh2-based multifunctional liposomes for advanced breast cancer therapy. Int J Nanomedicine. 2024;19:2879\u201388. https:\/\/doi.org\/10.2147\/ijn.S437733.","journal-title":"Int J Nanomedicine"},{"issue":"7","key":"2123_CR25","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/j.apsb.2020.11.019","volume":"11","author":"C Li","year":"2021","unstructured":"Li C, Sun T, Jiang C. Recent advances in nanomedicines for the treatment of ischemic stroke. Acta Pharm Sin B. 2021;11(7):1767\u201388. https:\/\/doi.org\/10.1016\/j.apsb.2020.11.019.","journal-title":"Acta Pharm Sin B"},{"key":"2123_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.883946","volume":"13","author":"Z Qi","year":"2022","unstructured":"Qi Z, Yan Z, Wang Y, et al. Ginsenoside Rh2 inhibits NLRP3 inflammasome activation and improves exosomes to alleviate hypoxia-induced myocardial injury. Front Immunol. 2022;13:883946. https:\/\/doi.org\/10.3389\/fimmu.2022.883946.","journal-title":"Front Immunol"},{"issue":"6","key":"2123_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abj1262","volume":"8","author":"J Xia","year":"2022","unstructured":"Xia J, Ma S, Zhu X, et al. Versatile ginsenoside Rg3 liposomes inhibit tumor metastasis by capturing circulating tumor cells and destroying metastatic niches. Sci Adv. 2022;8(6):eabj1262. https:\/\/doi.org\/10.1126\/sciadv.abj1262.","journal-title":"Sci Adv"},{"key":"2123_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/biom10030444","author":"D-S Im","year":"2020","unstructured":"Im D-S. Pro-resolving effect of ginsenosides as an anti-inflammatory mechanism of Panax ginseng. Biomolecules. 2020. https:\/\/doi.org\/10.3390\/biom10030444.","journal-title":"Biomolecules"},{"key":"2123_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108328","volume":"241","author":"Z Zhao","year":"2023","unstructured":"Zhao Z, Pan Z, Zhang S, et al. Neutrophil extracellular traps: a novel target for the treatment of stroke. Pharmacol Ther. 2023;241:108328. https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108328.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"2123_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-023-00463-x","volume":"10","author":"W-J Tu","year":"2023","unstructured":"Tu W-J, Wang L-D. China stroke surveillance report 2021. Mil Med Res. 2023;10(1):33. https:\/\/doi.org\/10.1186\/s40779-023-00463-x.","journal-title":"Mil Med Res"},{"key":"2123_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112719","volume":"148","author":"T Zhu","year":"2022","unstructured":"Zhu T, Wang L, Wang L-P, Wan Q. Therapeutic targets of neuroprotection and neurorestoration in ischemic stroke: applications for natural compounds from medicinal herbs. Biomed Pharmacother=Biomedecine & pharmacotherapie. 2022;148:112719. https:\/\/doi.org\/10.1016\/j.biopha.2022.112719.","journal-title":"Biomed Pharmacother=Biomedecine & pharmacotherapie"},{"key":"2123_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14030256","author":"C Penna","year":"2025","unstructured":"Penna C, Pagliaro P. Endothelial dysfunction: redox imbalance, NLRP3 inflammasome, and inflammatory responses in cardiovascular diseases. Antioxidants. 2025. https:\/\/doi.org\/10.3390\/antiox14030256.","journal-title":"Antioxidants"},{"issue":"12","key":"2123_CR33","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.2174\/1570159x18666200720173316","volume":"18","author":"Y Yang","year":"2020","unstructured":"Yang Y, Torbey MT. Angiogenesis and blood-brain barrier permeability in vascular remodeling after stroke. Curr Neuropharmacol. 2020;18(12):1250\u201365. https:\/\/doi.org\/10.2174\/1570159x18666200720173316.","journal-title":"Curr Neuropharmacol"},{"key":"2123_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124164","volume":"657","author":"C Wang","year":"2024","unstructured":"Wang C, Gamage PL, Jiang W, Mudalige T. Excipient-related impurities in liposome drug products. Int J Pharm. 2024;657:124164. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124164.","journal-title":"Int J Pharm"},{"issue":"4","key":"2123_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2023.100685","volume":"47","author":"K-Y Wong","year":"2024","unstructured":"Wong K-Y, Wong M-S, Liu J. Aptamer-functionalized liposomes for drug delivery. Biomed J. 2024;47(4):100685. https:\/\/doi.org\/10.1016\/j.bj.2023.100685.","journal-title":"Biomed J"},{"key":"2123_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112836","volume":"149","author":"L Yu","year":"2022","unstructured":"Yu L, Zhang Y, Chen Q, et al. Formononetin protects against inflammation associated with cerebral ischemia-reperfusion injury in rats by targeting the JAK2\/STAT3 signaling pathway. Biomed Pharmacother= Biomedecine & pharmacotherapie. 2022;149:112836. https:\/\/doi.org\/10.1016\/j.biopha.2022.112836.","journal-title":"Biomed Pharmacother= Biomedecine & pharmacotherapie"},{"issue":"2","key":"2123_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117262","volume":"319","author":"M Lu","year":"2024","unstructured":"Lu M, Yin J, Xu T, et al. Fuling-zexie formula attenuates hyperuricemia-induced nephropathy and inhibits JAK2\/STAT3 signaling and NLRP3 inflammasome activation in mice. J Ethnopharmacol. 2024;319(2):117262. https:\/\/doi.org\/10.1016\/j.jep.2023.117262.","journal-title":"J Ethnopharmacol"},{"key":"2123_CR38","doi-asserted-by":"publisher","unstructured":"Lu P, Shen R, Yang J, Wu L, Wang R. Dynamic regulation and targeted interventions of macrophages in ischemia-reperfusion injury. J Adv Res. 2025. https:\/\/doi.org\/10.1016\/j.jare.2025.05.006.","DOI":"10.1016\/j.jare.2025.05.006"},{"key":"2123_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.714943","volume":"12","author":"H Zhu","year":"2021","unstructured":"Zhu H, Jian Z, Zhong Y, et al. Janus kinase inhibition ameliorates ischemic stroke injury and neuroinflammation through reducing NLRP3 inflammasome activation via JAK2\/STAT3 pathway inhibition. Front Immunol. 2021;12:714943. https:\/\/doi.org\/10.3389\/fimmu.2021.714943.","journal-title":"Front Immunol"},{"issue":"1","key":"2123_CR40","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12640-021-00456-5","volume":"40","author":"N Ji","year":"2022","unstructured":"Ji N, Wu L, Shi H, et al. VSIG4 attenuates NLRP3 and ameliorates neuroinflammation via JAK2-STAT3-A20 pathway after intracerebral hemorrhage in mice. Neurotox Res. 2022;40(1):78\u201388. https:\/\/doi.org\/10.1007\/s12640-021-00456-5.","journal-title":"Neurotox Res"},{"key":"2123_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-020-00327-9","volume":"15","author":"Z Lu","year":"2020","unstructured":"Lu Z, Xiong W, Xiao S, et al. Huanglian jiedu decoction ameliorates DSS-induced colitis in mice via the JAK2\/STAT3 signalling pathway. Chin Med. 2020;15:45. https:\/\/doi.org\/10.1186\/s13020-020-00327-9.","journal-title":"Chin Med"},{"key":"2123_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26178336","author":"Z Li","year":"2025","unstructured":"Li Z, Li M, Fang Z, Wang H. Immunological mechanisms and therapeutic strategies in cerebral ischemia-reperfusion injury: from inflammatory response to neurorepair. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26178336.","journal-title":"Int J Mol Sci"},{"key":"2123_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197406","author":"P Faris","year":"2020","unstructured":"Faris P, Negri S, Perna A, et al. Therapeutic potential of endothelial colony-forming cells in ischemic disease: strategies to improve their regenerative efficacy. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21197406.","journal-title":"Int J Mol Sci"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02123-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-026-02123-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02123-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T19:58:12Z","timestamp":1776628692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-026-02123-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,19]]},"references-count":43,"alternative-id":["2123"],"URL":"https:\/\/doi.org\/10.1007\/s13346-026-02123-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8550026\/v1","asserted-by":"object"}]},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,19]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiments in this study have been approved by the local ethics committee of Guizhou University of Chinese Medicine (approval number: 20250605003), and all ARRIVE standards have been followed\n                      .\n                      Adult male Sprague\u2013Dawley (SD) rats (220\u2009\u00b1\u200920 g) were purchased from Henan Sikebeisi Biotechnology Co. Ltd. The experimental license number is SCXK (Yu) 2020\u20130005, The license number for the use is SCXK (Qian) 2021\u20130005. They were raised at a temperature of 25\u2009\u00b1\u20092 \u00b0C, a relative humidity of 60\u2009\u00b1\u200910%, and a natural light\u2013dark cycle. For at least seven days, they were given access to water and given certifed standard meals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and informed consent"}},{"value":"All participants provided written informed consent prior to the publication of related data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}